Biocryst Pharmaceuticals (BCRX) Revenue: 2010-2015
Historic Revenue for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to $11.0 million.
- Biocryst Pharmaceuticals' Revenue rose 239.31% to $11.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $45.0 million, marking a year-over-year increase of 140.46%. This contributed to the annual value of $13.6 million for FY2014, which is 21.48% down from last year.
- Latest data reveals that Biocryst Pharmaceuticals reported Revenue of $11.0 million as of Q3 2015, which was down 49.55% from $21.8 million recorded in Q2 2015.
- Over the past 5 years, Biocryst Pharmaceuticals' Revenue peaked at $21.8 million during Q2 2015, and registered a low of -$1.2 million during Q1 2012.
- Moreover, its 3-year median value for Revenue was $3.6 million (2013), whereas its average is $6.4 million.
- Per our database at Business Quant, Biocryst Pharmaceuticals' Revenue plummeted by 121.34% in 2012 and then skyrocketed by 1,385.47% in 2015.
- Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Revenue stood at $5.2 million in 2011, then tumbled by 121.34% to -$1.2 million in 2012, then surged by 170.78% to $10.6 million in 2013, then slumped by 48.46% to $5.4 million in 2014, then soared by 239.31% to $11.0 million in 2015.
- Its Revenue was $11.0 million in Q3 2015, compared to $21.8 million in Q2 2015 and $6.8 million in Q1 2015.